Avere Raises $500M to Advance Weekly Oral IL-23 Therapy
San Francisco, California, USA, August 10, 2026 Avere Therapeutics, Inc. has announced a $500 million private placement from a...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
San Francisco, California, USA, August 10, 2026 Avere Therapeutics, Inc. has announced a $500 million private placement from a...
Staten Island, New York, USA, August 10, 2026 Acurx Pharmaceuticals, Inc. has announced a new scientific partnership with Leiden...
